Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
The Johnson and Johnson vaccine was authorised for emergency use in February last year.
Full Article
Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
DNA
0 shares
1 views
You might like
Related news coverage
FDA Restricts J&J's COVID-19 Vaccine Due To Blood Clot Risk
Newsy
Watch VideoU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing..
Advertisement
More coverage
FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk
USATODAY.com
According to the FDA, the J & J COVID-19 vaccine should only be given to people who can't receive other vaccines or those who..
-
FDA Drastically Reduces Use Of Johnson & Johnson Vaccine Over Blood Clots
Daily Caller
-
FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot risk
CBS 2
-
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
SeattlePI.com
-
FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine
Upworthy